20 articles
Oxford researchers tested whether spermidine could rejuvenate aging immune systems and improve vaccination effectiveness in adults over 65.
French researchers tracked how kidney failure and dialysis speed up immune cell aging, revealing new connections between organ health and longevity.
A completed Phase 2 trial investigates the immune mechanisms behind age-related vaccine failure in older adults.
Small study tests synbiotic supplements to combat age-related immune decline in healthy elderly adults.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
12-week omega-3 trial tested whether fish oil could reverse accelerated immune system aging in HIV-infected older adults.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
A terminated RCT explored whether immunotype-targeted supplements could reduce iAge®, an AI-derived biomarker of chronic inflammation and immune aging.
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
University study tests whether combining probiotics with prebiotics can restore healthy gut bacteria and immune function in people over 65.
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
NYU study reveals how targeted immune therapy transforms inflammatory responses in rheumatoid arthritis treatment.
A Phase 4 trial compares two antiretroviral strategies in treatment-naive HIV patients with dangerously low CD4 counts below 100.
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.
French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
